| Family: | Blackrock (iShares) |
| Name: | iShares Biotechnology ETF |
| Inception Date: | 5-Feb-2001 |
| Termination Date: | |
| Investment Objective: | The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. It provides exposure to U.S. companies in the biotechnology industry. |
| Prospectus | |
| Top 10 Holdings | ||
| AMGEN INC | AMGN | 8.4031% |
| VERTEX PHARMACEUTICALS | VRTX | 7.8917% |
| GILEAD SCIENCES INC | GILD | 7.0245% |
| REGENERON PHARMACEUTICALS | REGN | 5.8141% |
| MODERNA INC | MRNA | 4.3416% |
| ARGENX SE ADR | ARGX | 3.6772% |
| NATERA | NTRA | 3.0419% |
| REVOLUTION MEDICINES | RVMD | 2.8005% |
| BIOGEN | BIIB | 2.2221% |
| ALNYLAM PHARMACEUTICALS | ALNY | 2.2103% |
| Top 10 Holdings Weight: | 47.4% |
| Number of Holdings: | 253 |
| Shares Outstanding: | 50,300,000 |
| Total Net Assets: | 10,604,748,800 |
| NAV: | 210.77 |
| Net Expense Ratio: | 0.44% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Biotech |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Large & Mid Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
